The researchers reported significantly higher mRNA expression for P2X7R, NLRP3, caspase-1, IL-18, and IL-1β in patients with SS who developed MALT-NHL over the follow-up, compared to both SS patients who did not develop lymphoma and controls. The gene discussed is CASP1; the disease is synovial sarcoma.